POPULATION PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA FOLLOWING SUBCUTANEOUS INFUSION

被引：0
|
作者：
Birnberg, T. [1 ]
Adar, L. [1 ]
Smania, G. [2 ]
Bjornsson, M. [2 ]
Jonsson, N. [2 ]
Case, R. [2 ]
Karlsson, M. O. [3 ]
机构：
[1] NeuroDerm, Rehovot, Israel
[2] Pharmetheus, Uppsala, Sweden
[3] Uppsala Univ, Uppsala, Sweden
来源：
PARKINSONISM & RELATED DISORDERS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P 121
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [41] Continuous Subcutaneous Administration of Carbidopa Enhances Levodopa Pharmacokinetics: A Series of Studies Conducted in the Pig, Mouse and Healthy Volunteers
    Yacoby-Zeevi, Oron
    Zawoznik, Eduardo
    Weinstock, Irena
    Nemas, Mara
    Caraco, Yossi
    LeWitt, Peter
    Oren, Sheila
    Shaltiel-Karyo, Ronit
    NEUROLOGY, 2016, 86
  • [42] Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
    Bergquist, Filip
    Ehrnebo, Mats
    Nyholm, Dag
    Johansson, Anders
    Lundin, Fredrik
    Odin, Per
    Svenningsson, Per
    Dizdar, Nil
    Eriksson, Elias
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (09): : 1095 - 1102
  • [43] Pharmacokinetics of Accordion Pill™ Carbidopa/Levodopa Following Multiple Doses in Patients With Parkinson's Disease
    Olanow, C.
    Stocchi, F.
    Leinonen, M.
    Navon, N.
    Meckler, J.
    Gendreau, R.
    MOVEMENT DISORDERS, 2019, 34
  • [44] Subcutaneous Administration of Carbidopa Enhances Oral Levodopa Pharmacokinetics: A Series of Studies Conducted in Pigs, Mice, and Healthy Volunteers
    Shaltiel-Karyo, Ronit
    Caraco, Yoseph
    Zawaznik, Eduardo
    Weinstock, Irena
    Nemas, Mara
    Oren, Sheila
    Yacoby-Zeevi, Oron
    LeWitt, Peter A.
    CLINICAL NEUROPHARMACOLOGY, 2019, 42 (04) : 111 - 116
  • [45] Pharmacokinetics and pharmacodynamics of levodopa/carbidopa cotherapies for Parkinson's disease
    Mueller, Thomas
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (05) : 403 - 414
  • [46] THE EFFECT OF AGE ON THE PHARMACOKINETICS OF LEVODOPA ADMINISTERED ALONE AND IN THE PRESENCE OF CARBIDOPA
    ROBERTSON, DRC
    WOOD, ND
    EVEREST, H
    MONKS, K
    WALLER, DG
    RENWICK, AG
    GEORGE, CF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (01) : 61 - 69
  • [47] Quality of life with continuous subcutaneous levodopa/carbidopa infusion: Exploratory findings from the ND0612 BeyoND study
    Espay, Alberto
    Yardeni, Tami
    Adar, Liat
    Case, Ryan
    Poewe, Werner
    Isaacson, Stuart
    MOVEMENT DISORDERS, 2023, 38 : S16 - S16
  • [48] A case of Perry Syndrome responding to intestinal infusion of carbidopa/levodopa
    Hamed, Moath
    Shetty, Aakash
    Tremain, Genise
    Lazarescu, Adriana
    Suchowersky, Oksana
    PARKINSONISM & RELATED DISORDERS, 2019, 61 : 236 - 237
  • [49] ND0612 (levodopa/carbidopa for subcutaneous infusion) achieves stable levodopa plasma levels when administered in low and high doses in patients with PD
    Giladi, N.
    Caraco, Y.
    Gurevich, T.
    Djaldetti, R.
    Adar, L.
    Minei, T. Rachmilewitz
    Oren, S.
    MOVEMENT DISORDERS, 2017, 32
  • [50] THE EFFECT OF CARBIDOPA ON AGE-RELATED CHANGES IN THE PHARMACOKINETICS OF LEVODOPA
    ROBERTSON, DRC
    WOOD, N
    EVEREST, H
    WALLER, DG
    RENWICK, AG
    GEORGE, CF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (01) : P106 - P106
12345